Nausea on a GLP-1: what may help and when to call
Nausea is a common effect of GLP-1 medicines, most often reported during dose increases. In Wegovy weight-reduction trials, 44% of adults on the injection reported nausea versus 16% on placebo. The Medication Guide says to tell your healthcare provider right away about nausea, vomiting or diarrhea that does not go away, and to stop the medicine and call right away for severe abdominal pain that will not go away.
Quick answer
Nausea is a common effect of GLP-1 medicines, most often reported during dose increases. In Wegovy weight-reduction trials, 44% of adults on the injection reported nausea versus 16% on placebo. The Medication Guide says to tell your healthcare provider right away about nausea, vomiting or diarrhea that does not go away, and to stop the medicine and call right away for severe abdominal pain that will not go away.
How common is it?

GI reactions in Wegovy trials
In clinical trials for weight reduction in adults, 73% of people on Wegovy injection reported a gastrointestinal reaction versus 47% on placebo. Nausea was 44% vs 16%, vomiting 25% vs 6%, diarrhea 30% vs 16%. Severe gastrointestinal reactions were reported by 4.1% vs 0.9%. The label says these reactions were most often reported during dose escalation. Stopping the medicine because of nausea was uncommon but higher than placebo (1.8% vs 0.2%). Source: Wegovy label sections 5.6 and 6.1.
Label note: Table 3 reports vomiting in 24% of Wegovy injection recipients; the gastrointestinal-reactions narrative in section 6.1 reports 25%. This is a difference within the label, not two separate comparison trials. The figure follows the gastrointestinal-reactions narrative.
Notice the pattern
Useful details for a clinician: when the nausea starts relative to the dose day, whether a dose was recently increased, how it relates to meals, how much you can drink, and any other symptoms such as pain, fever, or vomiting.
What may help
The label’s main measure is built into the treatment plan: doses start low and increase gradually, and the label says escalation may be delayed if a dose is not tolerated. Whether to slow down, pause, or change a dose is the prescriber’s decision. Do not skip or change doses on your own.
The Medication Guide also says it is important to drink fluids to help reduce the chance of dehydration. Source: Wegovy Medication Guide.
The 2025 joint advisory from four U.S. nutrition and obesity societies (a consensus document for clinicians, not a clinical trial) describes these everyday measures for GLP-1 nausea, which are most useful early in treatment or after a dose increase. Source 3.
- Nausea is often worse in the morning or after long periods without eating.
- Smaller, more frequent meals, and avoiding fatty or high-fiber foods during the first few days of treatment, can help.
- Some people get caught in a cycle of not eating because of nausea, which can make nausea worse.
- Ginger or peppermint tea and acupressure bands are described as possibly helpful.
- Large meals make vomiting more likely.
- Dehydration from severe nausea, vomiting or diarrhea can harm the kidneys, so preventing it matters.
- Anti-nausea medicines exist. The choice depends on the person, and some types can worsen constipation, so that is a prescriber decision.
These are expert recommendations, not label instructions. Tell your care team if you try them and symptoms continue.
When to contact care: what the Medication Guide says
From the Wegovy Medication Guide, symptom first, then what it says. Other products have their own guides.
- Severe pain in the stomach area that will not go away, with or without nausea or vomiting; pain may go to the back (possible pancreatitis): Stop using Wegovy and call your healthcare provider right away
- Nausea, vomiting or diarrhea that does not go away (risk of dehydration and kidney problems): Tell your healthcare provider right away
- Severe stomach problems, or stomach problems that will not go away: Tell your healthcare provider
- Upper stomach pain, fever, yellowing of skin or eyes, or clay-colored stools (possible gallbladder problems): Call your healthcare provider
- Swelling of face, lips, tongue or throat; severe rash or itching; problems breathing or swallowing; very rapid heartbeat; fainting (serious allergic reaction): Stop using Wegovy and get medical help right away
The label also notes that acute kidney injury has been reported, mostly in people who became dehydrated from nausea, vomiting or diarrhea, and that it does not recommend Wegovy in severe gastroparesis (label sections 5.5 and 5.6). In the label’s adult trials, gallstones (cholelithiasis) were reported by 1.6% vs 0.7%.
Matches the Wegovy Medication Guide as of Nov 17, 2026. Clinical sign-off pending.
What this does not establish
Trial rates describe groups of people, not what you will feel. Rates vary by product, dose, and population. This page does not diagnose a cause of nausea. Nausea has many causes, and not every case on a GLP-1 is from the medicine.
FAQs
What should I know about nausea on a GLP-1? It is common, often tied to dose increases, and usually reported early. Persistent or severe symptoms need care.
When should I seek urgent care? The Medication Guide says to stop Wegovy and call right away for severe stomach pain that will not go away, and to stop it and get medical help right away for signs of a serious allergic reaction. For any emergency, call your local emergency number.
What details should I share with my clinician? Timing, dose changes, food and fluid intake, other symptoms, and other medicines.
Sources
Source methods and reading limits
Sources checked against Europe PMC abstracts and product-label text: November 17, 2026. Full text was not read for abstract-only claims. Source dates and reading limits are recorded with the supporting references.